Archive - February 2018
US clears AZ’ Imfinzi for lung cancer
Calcium may play a role in the development of Parkinson’s disease
Celgene reveals strong P3 Otezla data in rare inflammatory condition
Long-running, $2.5bn lawsuit swings in Gilead’s favour
AZ’s Imfinzi seals blockbuster lung cancer market with FDA nod
FDA Approves Osmolex ER (amantadine) for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions
Could Apple’s move into EHR allow pharma to connect directly to patients?
Investigator Detail in Open Payments